Market Place
Sourcing Support
Advancell`s 212Pb-Advc001 Shows Safety And Anti-Tumor Activity
18 Oct 2025 //
GLOBENEWSWIRE
Advancell Names Andrew Kay Chair Of Board
16 Oct 2025 //
GLOBENEWSWIRE
AdvanCell to present promising clinical trial results of ADVC001
12 Oct 2025 //
GLOBENEWSWIRE
Advancell Showcases Pb-212 Targeted Alpha Therapy For Cancer
29 Sep 2025 //
GLOBENEWSWIRE
AdvanCell gets $18M for Prostate Cancer Therapy from MRFF Frontiers
13 Apr 2025 //
BUSINESSWIRE
Lilly inks AdvanCell deals to expand in radiopharma
11 Feb 2025 //
BUSINESSWIRE
AdvanCell Completes Oversubscribed $112M Series C Financing
03 Feb 2025 //
BUSINESSWIRE
Advancell: Leadership Team Expansion, Appointment Details
08 May 2024 //
BUSINESSWIRE
AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer
04 Jan 2024 //
BUSINESSWIRE
AdvanCell Announces First Patient Dosed in Phase I/II Trial of 212Pb-ADVC001
07 Nov 2023 //
BUSINESSWIRE
POINT Biopharma, AdvanCell Partner to Develop Lead-212-Labeled Radioligand
26 Jun 2023 //
CONTRACT PHARMA
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.